Clinical trials
Overweight trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 5 |
| S.LAB (SOLOWAYS) | 3 |
| Eli Lilly and Company | 2 |
| Eurasian Association of Therapists | 2 |
| I.M. Sechenov First Moscow State Medical University | 2 |
| National Medical Research Center for Therapy and Preventive Medicine | 2 |
| Federal State Budgetary Scientific Institution | 1 |
| Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology | 1 |
| National Research Center for Preventive Medicine | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 20 |
| Obesity | 19 |
| Nutrition Disorders | 4 |
| Diabetes Mellitus | 3 |
| Hypertension | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Asthma | 2 |
| COVID-19 | 2 |
| Coronary Disease | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.